245 related articles for article (PubMed ID: 14695186)
1. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
Moullan N; Cox DG; Angèle S; Romestaing P; Gérard JP; Hall J
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1168-74. PubMed ID: 14652276
[TBL] [Abstract][Full Text] [Related]
3. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
[TBL] [Abstract][Full Text] [Related]
4. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.
Brem R; Cox DG; Chapot B; Moullan N; Romestaing P; Gérard JP; Pisani P; Hall J
Carcinogenesis; 2006 Dec; 27(12):2469-74. PubMed ID: 16829685
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
[TBL] [Abstract][Full Text] [Related]
6. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
7. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
Vaclavicek A; Bermejo JL; Schmutzler RK; Sutter C; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Burwinkel B; Bartram CR; Hemminki K; Försti A
Endocr Relat Cancer; 2007 Jun; 14(2):267-77. PubMed ID: 17639043
[TBL] [Abstract][Full Text] [Related]
10. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
[TBL] [Abstract][Full Text] [Related]
12. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
[TBL] [Abstract][Full Text] [Related]
13. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
Offit K; Gilad S; Paglin S; Kolachana P; Roisman LC; Nafa K; Yeugelewitz V; Gonzales M; Robson M; McDermott D; Pierce HH; Kauff ND; Einat P; Jhanwar S; Satagopan JM; Oddoux C; Ellis N; Skaliter R; Yahalom J
Clin Cancer Res; 2002 Dec; 8(12):3813-9. PubMed ID: 12473594
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
16. ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
Zhang L; Yang M; Bi N; Fang M; Sun T; Ji W; Tan W; Zhao L; Yu D; Lin D; Wang L
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1360-8. PubMed ID: 20171797
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
